retatrutide vs semaglutide vs tirzepatide and Tirzepatide: GLP-3 Facts explained switching to retatrutide from tirzepatide

Glucagon-like peptide 1 receptor agonists in patients with inflammatory arthritis or psoriasis: a scoping review

If you are comparing the most common reactions people report, the article on common GLP-1 side effects is a helpful companion read

However, current evidence comes primarily from observational studies rather than large randomized controlled trials designed specifically to test semaglutide for nicotine cessation

For most people, a daily liposomal routine offers the best balance of high bioavailability and convenience

That gradual titration is deliberate

In the TRIUMPH-1 Phase 3 trial, participants on the maximum dose of retatrutide (12 mg) lost an average of 28.3% of their body weight after 80 weeks, and up to 30.3% after 104 weeks in the study extension